SK&F 93574, a histamine H2-receptor antagonist, releases histamine in the dog.

J Pharm Pharmacol

Smith Kline & French Research Ltd., Welwyn, Herts, UK.

Published: January 1989

This study was designed to establish whether SK&F 93574 releases histamine in dogs. Three female beagle dogs each received single infusions (on separate days) of each of SK&F 93574 (2.5 mg kg-1), polyvinylpyrrolidone (PVP, 20 mg kg-1) and sterile saline. The treatments were given at 14 day intervals by rapid intravenous infusion at 0.5 mL kg-1 min-1 for 2 minutes. Dogs showed clinical signs of histamine release such as vasodilation, licking lips, head drooping and increased gut movement after treatment with the known histamine releaser PVP or the test compound SK&F 93574. These signs were of similar severity and duration for the two compounds. No such changes were observed when the dogs received vehicle alone. Treatment with PVP or SK&F 93574 also resulted in markedly elevated plasma histamine concentrations (greater than 10-fold increase over control). It is concluded that intravenous administration of SK&F 93574 to dogs is associated with histamine release.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.2042-7158.1989.tb06335.xDOI Listing

Publication Analysis

Top Keywords

sk&f 93574
24
releases histamine
8
dogs received
8
histamine release
8
histamine
7
sk&f
6
0
5
dogs
5
93574 histamine
4
histamine h2-receptor
4

Similar Publications

While all native tRNAs undergo extensive post-transcriptional modifications as a mechanism to regulate gene expression, mapping these modifications remains challenging. The critical barrier is the difficulty of readthrough of modifications by reverse transcriptases (RTs). Here we use Induro-a new group-II intron-encoded RT-to map and quantify genome-wide tRNA modifications in Induro-tRNAseq.

View Article and Find Full Text PDF

K2 channel positive modulation reduces alcohol drinking in female C57BL/6J mice.

Alcohol

January 2025

Department of Neuroscience, Charleston Alcohol Research Center, Medical University of South Carolina, 70 President Street, Drug Discovery Building, Charleston, SC 29425. Electronic address:

Although men have historically exhibited higher levels of alcohol use disorder (AUD) diagnosis, the gap between men and women has been diminishing quickly. Preclinical screening for pharmacological treatments for AUD has typically focused solely on males, ignoring the possibility that males and females may differ mechanistically for the same behavioral phenotype. To ensure the efficacy of treatment targets across the sexes, it is crucial to study the pharmacological effects of AUD treatments in males and females.

View Article and Find Full Text PDF

Immobilization of per- and polyfluorinated alkyl substances (PFAS) from field contaminated groundwater by a novel organo-clay vs. colloidal activated carbon under flow conditions.

J Hazard Mater

January 2025

University of Wuppertal, School of Architecture and Civil Engineering, Institute of Foundation Engineering, Water and Waste Management, Laboratory of Soil and Groundwater Management, Pauluskirchstraße 7, Wuppertal 42285, Germany. Electronic address:

Two novel and unique adsorptive materials, one (Fluorolock®) from clay mineral sepiolite coated with the cationic polymer polydiallyldimethylammionium chloride (pDADMAC) and the other (Intraplex®) from colloidal activated carbon were specially developed for the in situ remediation of per- and polyfluoroalkyl substances (PFAS) in the saturated zone. We evaluated the potential of both materials to immobilize PFAS in soils under flow conditions via soil column experiments using groundwater, which was contaminated with PFAS in the field. Furthermore, the potential ecotoxicological effects of both materials on aquatic organisms were assessed by exposing the soil column effluent to Daphnia magna.

View Article and Find Full Text PDF

Programmed cell death protein 1 (PDCD1) and cluster of differentiation 274 (CD274) expression is implicated in escaping tumors from immune surveillance. Immune checkpoint inhibitors show promise in cancer therapy, yet their efficacy in glioblastomas, particularly with IDH1 mutations, remains unclear. This study analyzed two independent NGS datasets (n = 577 and n = 153) from TCGA to investigate the expression of PDCD1 and CD274 in glioblastomas and their relationship with IDH1 mutations.

View Article and Find Full Text PDF

Resistance training (RT) load and volume are considered crucial variables to appropriately prescribe and manage for eliciting the targeted acute responses (i.e., minimizing neuromuscular fatigue) and chronic adaptations (i.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!